OptiNose (OPTN)
(Delayed Data from NSDQ)
$0.93 USD
-0.04 (-4.38%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $0.93 0.00 (0.51%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Brokerage Reports
0 items in cart
OptiNose, Inc. [OPTN]
Reports for Purchase
Showing records 1 - 3 ( 3 total )
Company: OptiNose, Inc.
Industry: Medical - Drugs
XHANCE Label Extension Defines First FDA Approval for CRSsNP Patients; Reit. Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Company: OptiNose, Inc.
Industry: Medical - Drugs
Near-Term XHANCE PDUFA for First Approval in Chronic Sinusitis Without Nasal Polyps; Initiating With Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Company: OptiNose, Inc.
Industry: Medical - Drugs
|